Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer||
||Other / NIH||
||12||All||up to 74 Years (Child, Adult, Older Adult)||NCT00118352||1959.00
|March 2005||July 2010||May 26, 2015||July 11, 2005||May 30, 2017||May 30, 2017||